FANCA promotes lung adenocarcinoma progression and is a potential target for epitope vaccine immunotherapy
These results demonstrated that the elevation of FANCA promotes malignant phenotype of LUAD, and the potential peptide P2 (SLLEFAQYL) derived from FANCA may be used as an epitope vaccine for the treatment of LUAD.
Authors
- Ruifang Zhong (ORCID: https://orcid.org/0000-0002-9997-5881)
- Falin Chen (ORCID: https://orcid.org/0000-0003-1957-8374)
- Yuhan Gan
- Jinhua Chen (ORCID: https://orcid.org/0000-0001-5089-0927)
- Liangyuan Chen (ORCID: https://orcid.org/0000-0002-5334-1656)
- Jianbin You
- Yanli Kang
Institutions
- Fujian Medical University (CN)
- Fuzhou University (CN)
Publication Details
- Journal
- Journal of Translational Medicine
- Published
- 2024-10-07
- DOI
- https://doi.org/10.1186/s12967-024-05675-w
- Citations
- 3
- Primary Topic
- Immunotherapy and Immune Responses
- Type
- article
- Field-Weighted Citation Impact
- 0.72
Funders
- Fujian Medical University
- Fujian Provincial Health Technology Project